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Background: Schmallenberg virus (SBV), discovered in continental Europe in late 2011, causes mild clinical signs in
adult ruminants, including diarrhoea and reduced milk yield. However, fetal infection can lead to severe malformation in
newborn offspring. Enzyme-linked immunosorbent assays (ELISA) are commercially available for detection of SBV-specific
antibodies in bovine sera and milk. Here we describe the development and evaluation of an indirect ELISA based on a
yeast derived recombinant SBV nucleocapsid protein (N) for the detection of SBV-specific antibodies in bovine saliva.
Development of a non-invasive test to detect antibodies in individual bovine saliva samples could potentially provide a
test suitable for calves and adult cattle. The aim of this study was to investigate the agreement between the levels of
antibodies (IgG) measured in milk and sera, and the level of antibodies (IgG and IgA) in saliva, in comparison with the
antibody levels detected in sera and milk with commercially available test.
Results: Serum, milk and saliva samples from 58 cows were collected from three dairy herds in Lithuania and tested for
the presence of SBV-specific antibodies. The presence of IgG antibodies was tested in parallel serum and milk samples,
while the presence of IgA and IgG antibodies was tested in saliva samples. The presence of SBV-specific IgG and IgA in
saliva was tested using an indirect ELISA based on a yeast-derived recombinant N protein. The presence of SBV-specific
IgG in milk and sera was tested in parallel using a commercial recombinant protein based test. The sensitivities of the
newly developed tests were as follows: 96 % for the IgG serum assay and 94 % for the IgG milk assay and 85 % and 98 %
for IgG and IgA in saliva tests, when compared with data generated by a commercial IgG assay.
Conclusions: Data from testing the saliva IgG and IgA and also the milk and serum IgG with indirect SBV-specific ELISAs
showed close agreement with the commercial serum and milk IgG assay data. The level of IgG in saliva was notably
lower in comparison to IgA. The newly developed method exhibits the potential to serve as an easily transferable tool for
epidemiological studies.
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Schmallenberg virus (SBV), which emerged recently in
Europe, was first reported in Germany in a farm near
the town of Schmallenberg in late 2011 [1]. Metage-
nomic analysis identified a novel Bunyaviridae family
Orthobunyavirus, which subsequently was isolated from
blood specimens of infected animals. Recent analysis* Correspondence: rasa.burneikiene@bti.vu.lt
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and Sathuperi viruses belonging to the Simbu serogroup
in Orthobunyavirus [2]. In cattle, clinical symptoms in-
clude fever, loss of appetite, reduced milk yield and diar-
rhoea. Also, SBV infection has been implicated in many
cases of severely malformed bovine and ovine offspring
[3–8]. Quantitative reverse transcriptase PCR (q-PCR) is
the primary diagnostic assay developed by laboratories
in affected countries [1]. This assay has limitations in de-
tecting infected individuals based on blood samples, as it
only detects viral RNA when the bovine is viraemic [9].is distributed under the terms of the Creative Commons Attribution 4.0
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(ELISA) to detect SBV-specific antibodies in serum and
milk samples became commercially available shortly
after the emergence of SBV (SBV indirect ELISA, IDvet,
France) [10, 11]. Testing of bulk tank milk samples by
ELISA has been advocated as a convenient way to deter-
mine herd-level exposure to SBV [12, 13].
With the availability of vaccines against SBV, it has be-
come important to test animals and apply the test results
for herd management. For example a positive bulk tank
milk sample indicates that herd-level vaccination is not
necessary as natural immunity is present. This test is
suitable for dairy farms, but not for males or young cat-
tle. Saliva has a number of advantages over serum for
diagnosis. Saliva collection is cheap, non-invasive, is easy
to store and transport. Currently a commercial saliva
based test for SBV-sero-testing is not available [14, 15].
The aim of this study was to compare the antibody
levels in sera, milk and saliva and to develop a method
for the detection of SBV-specific antibodies in the saliva
of cattle.
Methods
Recombinant SBV N antigen
The cloning of the SBV N gene and purification under de-
naturing conditions of the recombinant SBV N antigen
was recently described [16]. Our recent findings indicated
that the SBV N protein purified under native conditions
exhibited better antigenicity than the SBV N protein puri-
fied under denaturing conditions (See Additional file 1:
Figure S1 and Additional file 2: Figure S2). Higher OD
readings with positive sera could be obtained using SBV N
protein purified under native conditions (See Additional
file 2: Figure S2). Thus, for the development of new diag-
nostic kits, the SBV N protein purified under native condi-
tions seems to have better antigenic characteristics and
sero-diagnostic potential. Saccharomyces cerevisiae AH22-
214 yeast transformation with the plasmid vector was de-
scribed previously [16, 17]. In this study the pFGG-SBV-N
plasmid vector, containing non-tagged full length SBV N
protein coding sequence, was used for transformation.
After the transformation yeast cells were inoculated in
500 ml of YEPD growth medium supplemented with
5 mM formaldehyde and grown with shaking at 30 °C for
24 h. 500 ml of YEPG induction medium (yeast extract
1 %, peptone 2 %, galactose 5 % supplemented with 5 mM
formaldehyde) was added and the yeast cells were grown
for an additional 17 h. The cells were harvested, washed
with distilled water and frozen at -20 °C until further use.
Thawed cells were suspended in 34 ml of PBS at pH 7.4
and 34 g of glass beads (0.5 mm diameter, Sigma-Aldrich
Co., St. Louis, MO, USA) were added. Cells were dis-
rupted mechanically by vortexing at 4 °C for 7 min. The
lysates were cleared from debris by centrifugation at2000 × g for 3 min. The insoluble protein fraction was sep-
arated by centrifugation at 10,000 × g for 30 min at 4 °C.
The supernatant was collected and placed on top of a
70 %/60 %/50 %/40 % sucrose gradient in PBS in an ultra-
centrifuge tube. The proteins were centrifuged at
110,396 g for 15 h. The 70 % and 60 % gradients, contain-
ing the SBV N protein, were collected and concentrated
by centrifugation for 2 h at 37,000 rpm through 30 % su-
crose solution. The protein pellet, containing the SBV N
protein was suspended in 2 ml of PBS. The purity of the
resultant N protein was more than 90 % as suggested by
SDS-PAGE (See Additional file 1: Figure S1). Two ml of
glycerol were added and the protein was kept at -20 °C
until further use.
Sera, milk and saliva collection
Bovine blood, milk and saliva samples were collected in
September 2014 from dairy farms in different regions in
Lithuania. All bovines were clinically healthy at the time
of sampling. Samples were stored at -20 °C until tested.
Saliva specimens were collected using the Copan
Flocked Swabs (Copan, Brescia, Italy) device according
to the manufacturer’s instructions. The study was con-
ducted according to the Law on the Care, Keeping and
Use of Animals, No. 8-500 of the Republic of Lithuania.
This research does not need to be approved by an ap-
propriate ethics committee. This is not field studies or
experimental research on animals and it complies with
institutional, national, or international guidelines.
The sera were tested for antibodies against SBV using
a commercially available ELISA kit (ID Screen Schmal-
lenberg virus Indirect, IDvet, Grabels, France) [10] be-
fore testing with indirect ELISA with the recombinant
SBV N protein.
Reference sera, certified negative or positive for SBV-
specific antibodies, were kindly provided by Dr. H.
Schirrmeier (Friedrich Loeffter Institut, Germany; [18]).
Indirect IgG ELISA for detection of the SBV N protein-
specific antibodies in bovine serum
The ELISA was carried out as described by Lazutka
et al. [16].
Indirect IgG ELISA for the detection of SBV N protein-
specific antibodies in cow’s milk and saliva, and indirect
IgA ELISA for saliva
The following protocol was adopted after optimization of
the assays. Microtiter plates (Nerbe Plus GmbH, Winsen/
Luhe, Germany) were coated with 2 μg/ml of recombinant
SBV N protein in 100 μl of 0.05 M carbonate-bicarbonate
coating buffer (pH9.6) and incubated overnight at 4 °C.
Plates were washed three times with PBST (PBS and 1 %
Tween-20) and then blocked by the addition of 150 μl of
blocking buffer per well (1x Roti-Block, Carl Roth GmbH
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room temperature for 1 h. After blocking, the plates were
washed three times with PBST and 100 μl aliquots of milk
specimens, diluted 1:10 in PBST, and were added to the
wells. Plates were incubated for 1 h at 37 °C and washed
five times with PBST. One hundred μl aliquots of rabbit
anti-bovine IgG (Sigma-Aldrich Co., St. Louis, MO, USA)
conjugated to HRP, diluted 1:20,000 (v/v) in PBST, were
added to each well and the plates were incubated for 1 h
at 37 °C. After washing five times with PBST, 100 μl of
TMB substrate (Invitrogen, Frederick, USA) was added to
each well and the enzyme reaction was stopped with an
equal volume of 1 M H2SO4 solution, after 10 min. of in-
cubation. The optical density at 450 nm was determined
for each sample using an ELISA plate reader (Sunrise
Tecan, Mannedorf, Switzerland).
The protocol was similar for saliva anti-SBV IgA ELISA,
except saliva samples were diluted 1:3 in PBST and sheep
anti-bovine IgA, (AbD Serotec, Biorad, Kidlington, UK)
conjugated to HRP, were diluted 1:20,000 in PBST with
5 % RotiBlock and 1 % chicken serum (Gibco/Invitrogen,
Paisley, UK). For the saliva anti-SBV IgG ELISA 4 μg/ml
of the SBV N protein was used per well. Nunc Maxisorp
microtiter plates (Thermo Scientific, Roskilde, Denmark)
were blocked with 150 μl of 5 % chicken serum in PBS per
well. Saliva samples were diluted 1:3 and rabbit anti-
bovine Fab’2 IgG (LifeSpan BioSciences, Inc., Seattle WA,
USA) conjugated to HRP were diluted 1:30,000 in PBST
with 5 % Roti-Block and 1 % chicken serum.
Determining the cut-off values of the different ELISAs
The cut-off value of our serum anti-SBV IgG system was
calculated as follows: 27 serum samples that were nega-
tive according to the commercial indirect SBV ELISA
test were tested against the SBV N protein. The optical
density of a sample was divided by the optical density of
a reference serum [18] sample and a sample-to-positive
(S/P) value in percent was obtained for each sample. The
calculation of S/P values was performed according to
Breard et al. [10]. The cut-off value for the serum IgG sys-
tem was then determined using the following formula:
Cut off ¼ x1 þ x2 þ … þ xnð Þ=n þ 3
 SD x1; x2; …; xnð Þ
where x is an S/P value of the individual sample, n is the
number of samples and SD is the standard deviation of
the set of samples. The samples that showed reactivity
within the average plus 2*SD and average plus 3*SD
range were considered doubtful.
We did not have enough negative milk or saliva sam-
ples available for us to determine the cut-off values for
our milk and saliva assays. Instead, S/P values were cal-
culated after incubating milk or saliva samples with theclosely related hantavirus Andes nucleocapsid protein
[19]. Other authors also used different antigens for de-
termination of cut-off values. Starkey and co-authors
[20] report the use of glutathione S-transferase (GST)
tagged proteins in enzyme immunoassays (EIAs). They
have used GST as a control antigen to permit estimation
of background OD in EIAs. Lin and co-authors [21]
used a bovine bocavirus protein as a control antigen to
define the cut-off in ELISAs established to detect human
bocavirus specific antibodies.
The S/P cut-off values for milk IgG, serum IgG, saliva
IgA and saliva IgG were 30 %, 28 %, 15 % and 10.5 % ac-
cordingly. The cut-off values for these systems were de-
termined as described above.
Evaluation of diagnostic assays in different specimen
types
As a first step towards the development of an SBV N
ELISA, checkerboard titrations were performed to deter-
mine the optimal concentration of the SBV N antigen.
To optimize the plate coating, the recombinant SBV N
protein was immobilized on ELISA plates at four different
concentrations: 4 μg/ml; 2 μg/ml; 1 μg/ml; 0.5 μg/ml. To
determine the optimal milk sample dilution, milk samples
were serially diluted ranging from 1:5 to 1:50. Saliva sam-
ples were tested at dilutions ranging from 1:2 to 1:128.
The anti-bovine IgG conjugate was diluted from 1:10,000
to 1:80,000 and the anti-bovine IgA-HRP conjugate was
diluted from 1:5000 to 1:40,000. The three milk and saliva
samples that were used for the evaluation of the assay had
matching serum samples that were characterized by the
commercial test as a strong positive, weak positive and
negative. After the optimization the tests were used to
analyze bovine sera, milk and saliva samples.
Statistical analysis
Statistical significance between separate tests was calcu-
lated using MedCalc and Microsoft Excel 2007 software.
Results
Optimization of the assays
The optimal antigen concentration for plate coating as
determined by a checkerboard titration was 2 μg/ml for
milk IgG and saliva IgA assays and 4 μg/ml for saliva
IgG assay. Positive samples revealed significantly higher
OD values (0.6 – 2.8) with SBV N protein as compared
to the control hantavirus Andes N antigen (0.03–0.15).
It was decided to use a dilution of 1:10 for the milk
specimens and a saliva dilution of 1:3 as these dilutions
gave good discrimination between positive and negative
reactions and were more economical in the use of the
sample. Nerbe plus plates were used for milk IgG and
saliva IgA assays, but for saliva IgG assay we have
chosen Nunc Maxisorp plate, in order to increase the
Table 1 Comparison of bovine serum, milk and saliva samples
analyzed with newly developed indirect SBV N ELISA tests with
commercial IDvet serum or milk indirect IgG ELISAs
(A)
IDvet milk indirect ELISA
Positive Negative Total
Indirect milk IgG ELISA Positive 48 0 48
Negative 3 1 4
Total 51 1 52
(B)
IDvet serum indirect ELISA
Positive Negative Total
Indirect saliva IgG ELISA Positive 46 0 46
Negative 8 1 9
Total 54 1 55
(C)
IDvet serum indirect ELISA
Positive Negative Total
Indirect saliva IgA ELISA Positive 53 0 53
Negative 1 1 2
Total 54 1 55
(D)
Indirect saliva IgA ELISA
Positive Negative Total
Indirect saliva IgG ELISA Positive 45 1 46
Negative 8 1 9
Total 53 2 55
Comparison of commercial milk ELISA with our developed indirect milk IgG
ELISA (A), commercial serum ELISA with our indirect saliva IgG (B) and saliva
IgA (C) ELISA, between saliva IgG and IgA ELISAs (D)
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achieved using weak positive samples, when Nunc Maxi-
sorp plates were used for antigen coating. Nerbe plus
plates were not sufficient to detect specific IgG in saliva
with low antibody titers, therefore Nunc Maxisorp plate
was used to compensate low IgG levels in saliva. A
1:30,000 dilution of anti-bovine IgG -HRP conjugate,
and 1:20,000 dilution of anti-bovine IgA-HRP conjugate
gave the greatest discrimination between reactivity of
positive samples with SBV N antigen and the control
antigen - hantavirus Andes N protein.
The saliva sample and anti-bovine IgG/IgA conjugates
were diluted in PBS with 5 % Roti-block and 1 %
chicken serum solution. The solution was found to be
more effective in blocking non-specific binding, leading
to lower OD values for the negative control and there-
fore higher S/P ratios.
Comparison of SBV specific antibody response in milk
and saliva samples
Using the newly developed indirect IgG and IgA ELISAs
we analyzed sera and their matched milk and saliva samples
from 58 randomly selected dairy cows that had been tested
before with commercial serum IgG and milk IgG assays. 54
serum samples were positive, one sample was negative and
three samples were doubtful in commercial assay. The
doubtful serum samples were excluded from further exam-
ination. Fifty-two out of 54 positive serum samples were
also positive in our developed assay, while two samples
were doubtful. One sample was negative in both assays.
The agreement between the two tests for the serum IgG as-
says was 96.30 % (95 % Confidence Interval: 87.25 % -
99.55 %). A small correlation of 0.14 (p = 0.00515) between
the optical densities of the same serum samples in indirect
IgG SBV ELISA and in commercial ELISA was observed.
Further, 58 milk samples were screened with commer-
cial IDvet IgG ELISA test. Fifty-one positive and one
negative milk sample was determined by commercial
assay. 6 milk samples were determined as doubtful and
were excluded from further examination. The remaining
52 samples were tested with newly developed indirect
IgG ELISA test. Forty-eight samples were described as
positive and one sample was negative. 3 samples, which
were determined as positive in commercial test, were
doubtful in our test. All 48 positive milk samples in our
assay were also positive in commercial assay and the
negative sample in our assay was also negative in com-
mercial assay. Our indirect milk IgG assay achieved a
sensitivity of 94.12 % (95 % CI: 83.76 % - 98.77 %)
(Table 1-A). Based on these values 98 % cows were SBV
seropositive. The reproducibility of independently per-
formed ELISAs was high (R2 = 0.93). The correlation be-
tween the OD of milk samples in commercial and in our
developed assay was low (R2 = 0.15, p = 0.00597).We then tested if the 55 animals tested for anti-SBV
IgG in their serum contain SBV-specific IgG and IgA
antibodies in their matched saliva samples. Forty-six in-
dividuals were positive for SBV IgG antibodies in saliva.
Eight cows with no antibodies in saliva had mid-level
antibody titers in their sera (Table 1-B). The IgG anti-
body titer was lower in the saliva than in serum in all
cows tested. The only sample that was negative in serum
assay was also negative in saliva assay. Thus the sensitiv-
ity and specificity was 85.19 % (95 % CI: 72.88 % -
93.38 %) and 100 % (95 % CI: 2.5 % -100 %), respectively,
compared to the commercial IgG assay. A comparison
of saliva IgG and serum IgG pairs is shown in Fig. 1.
Fifty-three cows tested positive in saliva IgA test com-
pared to 54 positive cows in IDvet IgG test. One cow
tested negative in both serum IgG and saliva IgA assays
and one saliva sample was described as false-negative
(Table 1-C). The sensitivity of saliva IgA ELISA was
Fig. 1 Relationship between S/P ratios of individual saliva and serum samples. Saliva samples from dairy cows were tested with indirect IgG ELISA
using recombinant SBV N protein and serum samples were tested with commercial IgG IDvet ELISA. The horizontal line represent the cut-off value
of serum IgG IDvet ELISA, while the vertical line represent the cut-off value of saliva IgG test. Dashed line marks linear regression, R squared is the
coefficient of determination
Lazutka et al. BMC Veterinary Research  (2015) 11:237 Page 5 of 798.15 % (95 % CI: 90.11 % - 99.95 %). Forty-five saliva
samples were positive for the presence of SBV-specific
IgG’s out of 53 saliva IgA positives. Eight saliva samples
displayed reactivity below the cut-off value in IgG assay
while showing a positive reaction in an anti-SBV IgA
ELISA (Fig. 2). One saliva IgG positive sample was
negative in saliva IgA assay, while one sample was
negative in both assays (Table 1-D, Fig. 2). The sensitiv-
ity of the saliva IgG test compared to saliva IgA test is
84.91 % (95 % CI: 72.41 % - 93.25 %). There was no lin-
ear correlation (R2 = 0.0007) for saliva/serum IgG pairs
(Fig. 1). Linear regression analysis estimated the coeffi-
cient of determination (R2) between antibody concen-
tration in saliva IgG and saliva IgA at 0.44 with p value
of 2.24 * 10-8 (Fig. 2).Fig. 2 Relationship between S/P ratios of indirect saliva IgG and IgA assays
ELISAs using recombinant SBV N protein. The horizontal line represent the
cut-off value of saliva IgG test. Dashed line marks linear regression, R squarDiscussion
A commercially available antibody ELISA was recently eval-
uated [11, 13] to detect SBV-specific antibodies in serum
and milk samples. Our study aimed to evaluate antibody
screening assays for use on both individual milk and saliva
samples. We did this by comparing the results of individual
milk and saliva antibody testing to individual serum anti-
body testing. Milk and saliva sample collection is cheap,
noninvasive and animal welfare-friendly. However milk and
saliva samples are not sterile and are subject to bacterial
degradation over time. Furthermore, salivary composition is
influenced by the method of collection and the degree of
stimulation of salivary flow. Stimulation of salivation before
sample collection may lower antibodies concentration in
saliva. Dilution effect of fluids from the salivary glands. Saliva samples from dairy cows were tested with indirect IgG and IgA
cut-off value of saliva IgA test, while the vertical line represent the
ed is the coefficient of determination
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small quantities of antibody. Saliva contains antibodies in
concentrations that are 1000-fold less than those in blood.
Sensitive detection systems are thus needed to reveal the
utility of saliva as a diagnostic medium [14, 22].
Development of an assay for detection of antibodies in
milk and saliva required optimization of numerous pa-
rameters to maximize sensitivity and specificity. Initial
experiments optimized the concentration of SBV N pro-
tein used as coating antigen, selection of the microtest
plate, the dilution of the test milk and saliva, and the di-
lution of the HRP conjugated secondary antibody to pro-
vide the best discrimination between known positive and
negative specimens as determined by commercial test
with adequate serum sample.
Three serum samples and six milk samples were ex-
cluded from the study for being doubtful. Some authors
suggest repeating the tests with longer incubation times to
define the antibody status of doubtful samples, or they ex-
clude these samples from their investigation [23, 24]. As
the several samples taken over period of time from the
same bovine, were not available for the study, therefore
the doubtful samples were excluded from further study.
There was close agreement between matched serum
and milk IgG assays. The sensitivity of 96 % for serum
IgG assay compared to commercial serum IgG ELISA
was achieved. This shows a slight improvement over our
recently developed indirect serum anti-SBV IgG ELISA
[16], where the sensitivity of the assay was 95 %. A low
degree of correlation between optical densities of the
same serum samples in commercial and our tests was
observed and may suggest that different epitopes on the
nucleocapsid protein are recognized in these assays.
These results promoted the idea that our newly puri-
fied recombinant SBV N protein could also be used to
detect antibodies against SBV in milk or saliva samples.
All our developed assays agreed with the commercial
ones. The agreement of our newly developed milk IgG
assay with the commercial test was 94 %. Detection of
SBV-specific IgA in saliva yielded similar results, with
98 % sensitivity. However the saliva IgG assay is less sen-
sitive than the saliva IgA assay, probably because of a
lower IgG concentration in saliva [25].
After SBV infection antibodies against SBV can be
found in bovine serum, milk and saliva. The relationship
between individual serum and milk antibodies for SBV
was established by others [12]. We suggest using non-
invasive sample extraction methods when possible, as
antibodies against SBV are present in milk and saliva.
We show that IgA is a reliable marker for SBV diagno-
sis using bovine saliva samples. There are only few stud-
ies demonstrating the production of detectable levels of
viral-specific antibodies in bovine saliva samples. This is
the first description of a diagnostic assay to SBV basedon saliva samples. To date most research on cattle saliva
as a diagnostic sample has been carried out with regard to
foot and mouth disease virus (FMDV) diagnostics [26, 27].
Conclusions
We have shown that milk and saliva samples are suitable
substitutes for serum with minimal loss of sensitivity.
Therefore, milk and saliva specimens have the potential
to replace serum based screening in large-scale sero-
prevalence studies.
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Additional file 1: Figure S1. Analysis of yeast cell lysates and purified
SBV N proteins by Western Blot (A) and SDS-PAGE (B). M – Spectra Broad
Range Prestained Protein Ladder (Thermo Fisher Scientific Baltics, Vilnius,
Lithuania), 1 – lysate of S. cerevisiae yeast transformed with mock pFGG
plasmid, 2 – 6His- SBV N protein after nickel-affinity chromatography
purification under denaturing conditions, 3– SBV N protein after
ultracentrifugation in sucrose gradient. Western blotting was performed
using mouse monoclonal antibodies raised against SBV N, Mab code
8G10 [16]. (PDF 1256 kb)
Additional file 2: Figure S2. Comparison of the reference sera
reactivity with various antigens using IgG ELISA. Positive, weak positive
and negative bovine reference sera [18] were tested. Columns represent
antibody response against SBV N antigen purified under native conditions
(black colums), 6His-SBV N purified under denaturing conditions [16] (grey
columns) and control hantavirus Andes N antigen [19] (white columns). The
OD values are expressed as obtained in arbitrary units. Bars indicate average
values plus standard deviation. (PDF 187 kb)
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